We are live on ! Find out more
FCSC

Fibrocell Science Inc.
FCSC

Delisted

FCSC was delisted on the 12th of December, 2019.

22 hedge funds and large institutions have $10.6M invested in Fibrocell Science Inc. in 2019 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 2

74% more capital invested

Capital invested by funds: $6.1M → $10.6M (+$4.5M)

67% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 3

10% more funds holding

Funds holding: 2022 (+2)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

Holders
22
Holders Change
+2
Holders Change %
+10%
% of All Funds
0.48%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
5
Increased
4
Reduced
2
Closed
3
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
TS
1
Third Security
Virginia
$4.89M
Renaissance Technologies
2
Renaissance Technologies
New York
$2.26M +$47.8K +23,300 +3%
Vanguard Group
3
Vanguard Group
Pennsylvania
$1.17M +$2.4K +1,170 +0.3%
BCM
4
Beryl Capital Management
California
$883K +$612K +298,279 New
MP
5
MSD Partners
New York
$410K
Susquehanna International Group
6
Susquehanna International Group
Pennsylvania
$317K +$220K +107,069 New
Geode Capital Management
7
Geode Capital Management
Massachusetts
$287K
Morgan Stanley
8
Morgan Stanley
New York
$148K -$20.5K -10,000 -17%
Creative Planning
9
Creative Planning
Kansas
$40K
Cambridge Investment Research Advisors
10
Cambridge Investment Research Advisors
Iowa
$37K +$5.34K +2,602 +26%
SMC
11
S. Muoio & Co
New York
$35K +$23.8K +11,590 New
Northern Trust
12
Northern Trust
Illinois
$32K
BlackRock
13
BlackRock
New York
$25K
UBS Group
14
UBS Group
Switzerland
$19K -$2.64K -1,286 -17%
Deutsche Bank
15
Deutsche Bank
Germany
$19K +$12.7K +6,200 +1,550%
Wells Fargo
16
Wells Fargo
California
$7K
ADL
17
Asset Dedication LLC
California
$6K
Victory Capital Management
18
Victory Capital Management
Texas
$4K +$2.96K +1,442 New
Bank of America
19
Bank of America
North Carolina
$1K +$811 +395 New
RE
20
RBC Europe
United Kingdom
$41
BNP Paribas Financial Markets
21
BNP Paribas Financial Markets
France
$3
Bank of Montreal
22
Bank of Montreal
Ontario, Canada
-$71K -37,500 Closed
PAM
23
Panagora Asset Management
Massachusetts
-$38K -19,809 Closed
Millennium Management
24
Millennium Management
New York
-$26K -13,746 Closed

FCSC Hedge Fund Activity: Q3 2019 in Review

22 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Fibrocell Science Inc. (FCSC) for Q3 2019, worth a combined $10.6M — up 74% from $6.1M a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new FCSC positions and 3 closed out — a net gain of 2 holders — while 4 added to existing stakes and 2 trimmed.

The largest buyer was Beryl Capital Management, opening a new position worth an estimated $612K. The largest seller was Bank of Montreal, exiting entirely with an estimated $71K sold.

  • 22 institutional investors held Fibrocell Science Inc. (FCSC) as of Q3 2019, up from 20 in Q2 2019.
  • Funds reported $10.6M of Fibrocell Science Inc. stock for Q3 2019, up 74% quarter-over-quarter.
  • 5 funds opened new Fibrocell Science Inc. positions in Q3 2019 and 3 closed out, a net change of +2 holders.
  • The largest Fibrocell Science Inc. buyer in Q3 2019 was Beryl Capital Management, an estimated $612K added.
  • The largest Fibrocell Science Inc. seller in Q3 2019 was Bank of Montreal, an estimated $71K sold.

Based on aggregated 13F filings for Q3 2019.